4.6 Article

Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2012

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Review Environmental Sciences

PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer

Jeffrey Tosoian et al.

THESCIENTIFICWORLDJOURNAL (2010)

Article Anatomy & Morphology

Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray Technology

Gillian O'Hurley et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)

Review Urology & Nephrology

Prostate cancer: a serious disease suitable for prevention

John M. Fitzpatrick et al.

BJU INTERNATIONAL (2009)

Article Biochemical Research Methods

2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer

Jennifer C. Byrne et al.

JOURNAL OF PROTEOME RESEARCH (2009)

Article Urology & Nephrology

Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection

Martin Schostak et al.

JOURNAL OF UROLOGY (2009)

Article Medicine, General & Internal

Mortality Results from a Randomized Prostate-Cancer Screening Trial

Gerald L. Andriole et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Screening and Prostate-Cancer Mortality in a Randomized European Study

Fritz H. Schroeder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medical Laboratory Technology

LC-MS/MS quantification of Zn-α2 glycoprotein:: A potential serum biomarker for prostate cancer

Olga P. Bondar et al.

CLINICAL CHEMISTRY (2007)

Article Oncology

Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy

Susan M. Henshall et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Article Medicine, General & Internal

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower

IM Thompson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)